Medicxi Ventures Management’s Merus MRUS Stock Holding History

Medicxi Ventures Management’s Portfolio MRUS Stock Details MRUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,169,028	Closed	-$52.6M	–	5
2024 Q1	$52.6M	Sell	1,169,028 -430,972	-27%	-$17.5M	11.72%	4
2023 Q4	$44M	Hold	1,600,000	–	–	14.85%	2
2023 Q3	$37.7M	Hold	1,600,000	–	–	12.05%	4
2023 Q2	$42.1M	Hold	1,600,000	–	–	11.8%	4
2023 Q1	$29.4M	Hold	1,600,000	–	–	12.61%	3
2022 Q4	$24.8M	Hold	1,600,000	–	–	10.4%	5
2022 Q3	$32M	Hold	1,600,000	–	–	13.34%	4
2022 Q2	$36.2M	Hold	1,600,000	–	–	15.04%	4
2022 Q1	$42.3M	Hold	1,600,000	–	–	11.46%	4
2021 Q4	$50.9M	Hold	1,600,000	–	–	12.73%	3
2021 Q3	$35.2M	Hold	1,600,000	–	–	7.66%	4
2021 Q2	$33.7M	Hold	1,600,000	–	–	6.04%	4
2021 Q1	$33.4M	Hold	1,600,000	–	–	19.47%	3
2020 Q4	$28M	Hold	1,600,000	–	–	16.3%	3
2020 Q3	$19.2M	Hold	1,600,000	–	–	9.17%	3
2020 Q2	$25.7M	Hold	1,600,000	–	–	15.82%	3
2020 Q1	$19.4M	Hold	1,600,000	–	–	25.3%	2
2019 Q4	$22.5M	Buy	+1,600,000	New	+$25.7M	13.81%	3

Other funds holding MRUS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Medicxi Ventures Management's MRUS Position: Q2 2024 in Review

Medicxi Ventures Management sold out of Merus (MRUS) in Q2 2024, closing a stake of 1,169,028 shares — an estimated $52.6M sold.

Medicxi Ventures Management first reported a position in MRUS in Q4 2019 and held it in 18 quarters. The position peaked at $52.6M in Q1 2024. 179 funds tracked by Wall St. Rank hold MRUS as of Q2 2024.

Medicxi Ventures Management reported no remaining Merus position as of Q2 2024 after selling out during the quarter.
Medicxi Ventures Management sold 1,169,028 Merus shares in Q2 2024, an estimated $52.6M.
Medicxi Ventures Management first reported a position in Merus in Q4 2019 and held it in 18 quarters.
Medicxi Ventures Management's Merus position peaked at $52.6M in Q1 2024.
179 funds tracked by Wall St. Rank held Merus as of Q2 2024.

Based on Medicxi Ventures Management's 13F filing for Q2 2024, filed 16 Jul 2024.